Page last updated: 2024-08-22

dimyristoylphosphatidylcholine and Squamous Cell Carcinoma of Head and Neck

dimyristoylphosphatidylcholine has been researched along with Squamous Cell Carcinoma of Head and Neck in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Armes, SP; Avila-Olias, M; Battaglia, G; Canton, I; Cecchin, D; Colley, HE; Hearnden, V; Hu, K; MacNeil, S; Madsen, J; McKeating, JA; Murdoch, C; Thornhill, MH; Warren, N1

Other Studies

1 other study(ies) available for dimyristoylphosphatidylcholine and Squamous Cell Carcinoma of Head and Neck

ArticleYear
Polymersome-mediated delivery of combination anticancer therapy to head and neck cancer cells: 2D and 3D in vitro evaluation.
    Molecular pharmaceutics, 2014, Apr-07, Volume: 11, Issue:4

    Topics: Antineoplastic Agents; Carcinoma, Squamous Cell; Cell Line, Tumor; Dimyristoylphosphatidylcholine; Doxorubicin; Drug Delivery Systems; Head and Neck Neoplasms; Humans; Hydrogen-Ion Concentration; Paclitaxel; Polymethacrylic Acids; Squamous Cell Carcinoma of Head and Neck

2014